BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that President and CEO, John Beaver, has been invited to participate in the 2022 Virtual Growth Conference,...

ISB 1442 is a First-In-Class 2+1 Biparatopic BEAT® 2.0 Bispecific Antibody Targeting CD38 and CD47 Preclinical Data Suggest Higher Potency and Tumor Growth Inhibition for ISB 1442 Relative to...

CECO Environmental Corp. (Nasdaq: CECE), a leading environmentally focused, diversified industrial company whose solutions protect people, the environment and industrial equipment, today announced...

Alkermes plc (Nasdaq: ALKS) announced today that its Chief Executive Officer, Richard Pops, will participate in a fireside chat at the Stifel 2022 CNS Days on Tuesday, March 29, 2022 at 8:30 a.m....

Exhibit features live presentations and interactive content highlighting innovative allograft biologics for bone healing and joint reconstruction CHICAGO, March 22, 2022 /PRNewswire/ -- LifeNet...